...
首页> 外文期刊>Cancer science. >Circular RNA hsa_circ_001895 serves as a sponge of microRNA‐296‐5p to promote clear cell renal?cell carcinoma progression by regulating SOX12
【24h】

Circular RNA hsa_circ_001895 serves as a sponge of microRNA‐296‐5p to promote clear cell renal?cell carcinoma progression by regulating SOX12

机译:圆形RNA HSA_CIRC_001895用作MicroRNA-296-5P的海绵,以通过调节SOX12促进透明细胞肾?细胞癌进展

获取原文

摘要

There is an urgent need to find novel potential therapeutic targets for the diagnosis and treatment of clear cell renal cell carcinoma (ccRCC) due to its highly invasive ability as a common urological malignant tumor. Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression. We first used qRT‐PCR analysis to find dysregulated circRNAs in ccRCC. A novel circRNA, hsa_circ_001895, was upregulated in ccRCC specimens and associated with metastatic properties of ccRCC. However, the tumorigenic mechanism of hsa_circ_001895 on ccRCC is yet to be found. We first indicated that hsa_circ_001895 predicted a poor prognosis in ccRCC patients. Additionally, overexpression of hsa_circ_001895 not only promoted cell proliferation, invasion and migration of ccRCC, but also inhibited cell apoptosis, whereas hsa_circ_001895 knockdown reversed the effect on ccRCC progression. In?vivo s.c. xenotransplanted tumor model also showed that silencing hsa_circ_001895 could suppress in?vivo ccRCC growth. Mechanistically, hsa_circ_001895 directly binds with microRNA (miR)‐296‐5p and inhibits its expression. Moreover, sex determining region Y (SRY)‐box 12 (SOX12) was identified as a target of miR‐296‐5p, the expression of which was suppressed by miR‐296‐5p. Notably, the inhibitory effect of hsa_circ_001895 on ccRCC progression was reversed by miR‐296‐5p inhibitor. In general, our findings indicated that hsa_circ_001895 may sponge miR‐296‐5p and promote SOX12 expression, which is the underlying mechanism of hsa_circ_001895‐induced ccRCC progression.
机译:由于其高度侵入性能力作为常见的泌尿病尿道肿瘤,迫切需要寻找新的潜在治疗靶标进行诊断和治疗透明细胞肾细胞癌(CCRCC)。圆形RNA(Circrnas)已被指示为各种类型的肿瘤进展中的潜在临界介质。我们首先使用QRT-PCR分析来查找CCRCC中的失调Circrnas。新型CircrNA HSA_CIRC_001895在CCRCC标本中上调并与CCRCC的转移性质相关。然而,尚未发现CCRCC上的HSA_CIRC_001895的致瘤机制。我们首先表明HSA_CIRC_001895预测CCRCC患者的预后差。此外,HSA_CIRC_001895的过表达不仅促进了CCRCC的细胞增殖,侵袭和迁移,还抑制细胞凋亡,而HSA_CIRC_001895敲低逆转了对CCRCC进展的影响。在vivo s.c。异种翻转的肿瘤模型也表明,沉默HSA_CIRC_001895可以抑制?体内CCRCC生长。机械地,HSA_CIRC_001895与MicroRNA(MIR)-296-5P直接绑定并抑制其表达。此外,性测定区域Y(Sry)-box12(Sox12)被鉴定为miR-296-5p的靶标,其表达被miR-296-5p抑制。值得注意的是,MIR-296-5P抑制剂反转HSA_CIRC_001895对CCRCC进展的抑制作用。通常,我们的研究结果表明HSA_CIRC_001895可以海绵MIR-296-5P促进SOX12表达,这是HSA_CIRC_001895诱导的CCRCC进展的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号